TRANSDERMAL DELIVERY OF (E)-1,2,5,6-TETRAHYDRO-1-METHYL-3-PYRIDINE-CARBOXALDEHYDE-O-METHYLOXINE HCL AND RELATED COMPOUNDS IN THE TREATMENT OF COGNITIVE DISORDERS AND FOR ANALGESIA

摘要

Transdermal formulations containing O-substituted-1,2,5,6-tetrahydro-3-pyridine oximes or O-substituted-1,2,3,6-tetrahydro-4-pyridine oximes are disclosed. Methods of treating cognitive disorders and affecting analgesia using the transdermal formulations are also disclosed.